INTRAPERITONEAL CHEMOTHERAPY IN THE COMBINED TREATMENT OF DISSEMINATED GASTRIC STOMACH

Download full text PDF
Issue: 
2
Year: 
2015

Professor A. Chernousov, Academician of the Russian Academy of Sciences; Professor T. Khorobrykh, MD; D. Vychuzhanin, Candidate of Medical Sciences; N. Kharlov; R. Nurutdinov, Candidate of Medical Sciences; N. Drogalov, M. Lakhov I.M. Sechenov First Moscow State Medical University

The capabilities of intraperitoneal chemotherapy have recently attracted increasing attention. The use of subcutaneous port systems for intraperitoneal administration of chemicals is effective both in combination therapy for gastric malignancies and as a palliative treatment method for patients with unresectable gastric cancer. The authors describe their own experience with fully implantable subcutaneous peritoneal Port-A-Cath systems for combined chemotherapy of disseminated gastric cancer. The installation and operating maintenance of the system are detailed; possible complications during its operation and methods for their prevention are given; and long-term treatment results are assessed.
Keywords: 
intraperitoneal chemotherapy
gastric cancer
peritoneal carcinomatosis
peritoneal Port-A-Cath system

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Chernousov A.F., Horobryh T.V., Vychuzhanin D.V. i dr. Polnost'ju implantiruemye «port-sistemy» v kombinirovannom lechenii bol'nyh rakom zheludka i tolstoj kishki. Materialy II s'ezda ROHG, 130.
  2. Chernousov A.F., Horobryh T.V., Vychuzhanin D.V. i dr. Ispol'zovanie podkozhnyh «port-sistem» firmy PSH Medical v kombinirovannom lechenii bol'nyh rakom zheludka i tolstoj kishki. Aktual'nye voprosy hirurgicheskoj gastroenterologii.
  3. Chernousov A., Khorobrykh T., Vichuzhanin D. et al. Subcutaneous port systems use in the combined treatment of patients with gastric and colorectal canser. 2013, Berlin, Germany. Abstr. book: 411.
  4. Sugarbaker P. Rationale for postoperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy // Reg. Cancer Treat. – 1988; 1: 66.
  5. Harmon R., Sugarbaker P. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer // Int. Semin. Surg. Oncol. – 2005; 2 (1): 1477–80.
  6. Hiratsuka M., Furukawa H., Yasuda T. et al. Report of case who survived more than five years after repeated intraperitoneal chemotherapy with cisplatin and 5-fluorouracil for treatment of microscopically positive peritoneal dissemination of gastric cancer // Gan To Kagaku Ryoho. – 1998; 25 (9): 1445–8.
  7. Yonemura Y., Endou Y., Tochiori S. et al. Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer. – 2005; 32 (11): 1635–9.
  8. Maruyama M., Nagahama Y., Sato E. et al. Influence of intraperitoneal chemotherapy to a recurrence pattern of gastric cancer with serosal exposure // Gan To Kagaku Ryoho. – 2007; 34 (12): 1946–8.
  9. Akamo Y., Takeyama H., Hasegawa M. et al. Efficacy of intraperitoneal chemotherapy for peritoneal recurrence of gastric carcinoma // Gan To Kagaku Ryoho. – 2001; 28 (11): 1659–61.
  10. Hirono Y., Katayama K., Murakami M. et al. Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination // Gan To Kagaku Ryoho. – 2005; 32 (10): 1404–9.
  11. Koufuji K., Aoyagi K., Yano S. et al. Peritoneal dissemination of scirrhous type 4 gastric cancer // Gan To Kagaku Ryoho. – 2005; 32 (10): 1384–8.
  12. Kokufu I., Fukuda I., Miyake Y. et al. A case of unresectable gastric cancer responding to combined therapy with intraperitoneal cisplatinum administration and continuous intravenous infusion of 5-fluorouracil // Gan to Kagaku Ryoho. – 1995; 22 (14): 2107–9.
  13. Hirono Y., Fujimoto D., Nagano H. et al. The current situation and subjects of the intraperitoneal chemotherapy for peritoneal dissemination in gastric cancer // Gan To Kagaku Ryoho. – 2008; 35 (6): 891–5.
  14. Kurita A., Takashima S., Takayama T. et al. Intraperitoneal chemotherapy for gastric carcimoma combined with peritoneal dissemination by intraperitoneal catheter with a subcutaneous reservoir // Gan To Kagaku Ryoho. – 1994; 21 (14): 2439–44.
  15. Radulescu C., Tufeanu D., Mintioan C. et al. Intraperitoneal chemotherapy for advanced gastric cancer // TMJ. – 2009; 59 (1): 49–55.
  16. Yan T., Black D., Sugarbaker P. et al. A Systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer // Ann. Surg. Oncol. – 2007; 14: 2702–13.
  17. Walker J. Intraperitoneal chemotherapy requires expertise and should be the standard of care for optimally surgically resected epithelial ovarian cancer patients // Ann. Oncol. – 2013; 24.